Antimicrobial resistance in foodborne bacteria remains a critical public health concern in Europe, according to a recent report from the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC). Despite some progress, the battle against antibiotic-resistant bacteria is far from over.
The report highlights a concerning trend: resistance to commonly used antibiotics in Salmonella and Campylobacter is still widespread. For instance, a significant portion of these bacteria from both humans and food-producing animals remain resistant to ciprofloxacin, an essential antibiotic for treating severe infections. This resistance is particularly alarming as it limits treatment options and poses a serious threat to public health.
But there's a glimmer of hope. Some countries have reported a decline in antibiotic resistance in Salmonella and Campylobacter over time. This shows that targeted efforts can make a real difference. For example, resistance to ampicillin and tetracyclines in Salmonella from humans has decreased in 19 and 14 countries, respectively, over the past decade. Similarly, resistance to erythromycin, a first-line treatment for Campylobacter infections, has decreased in several countries.
However, the fight is not yet won. The detection of carbapenemase-producing E. coli bacteria in food-producing animals and meat is a cause for concern. Carbapenems are a last-resort antibiotic for humans, and their use in food-producing animals is unauthorized. The increasing number of detections and the need for further investigation highlight the complexity of the issue.
The report emphasizes the importance of a One Health approach, recognizing the interconnectedness of human health, animal health, and food production. It calls for continued and responsible use of antibiotics across all sectors, combined with effective infection prevention, animal health, and food safety practices, to slow the emergence and spread of antibiotic-resistant bacteria and protect public health in Europe.
In summary, while progress has been made, the battle against antimicrobial resistance is an ongoing challenge. It requires collective efforts and a comprehensive strategy to safeguard public health and ensure the effectiveness of antibiotics for generations to come.
